SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-070907
Filing Date
2015-10-15
Accepted
2015-10-15 16:53:56
Documents
11
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-20032_110q.htm 10-Q 336668
2 EX-31.1 a15-20032_1ex31d1.htm EX-31.1 10825
3 EX-31.2 a15-20032_1ex31d2.htm EX-31.2 10830
4 EX-32.1 a15-20032_1ex32d1.htm EX-32.1 6321
5 EX-32.2 a15-20032_1ex32d2.htm EX-32.2 6296
  Complete submission text file 0001104659-15-070907.txt   1331135

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20150831.xml EX-101.INS 178565
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20150831.xsd EX-101.SCH 14784
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20150831_cal.xml EX-101.CAL 15400
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20150831_def.xml EX-101.DEF 26370
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20150831_lab.xml EX-101.LAB 136600
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20150831_pre.xml EX-101.PRE 85406
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 151160496
SIC: 2835 In Vitro & In Vivo Diagnostic Substances